Sustained Enrollment Momentum
Total enrollment grew over 6% to ~97,000 students, marking the tenth consecutive quarter of enrollment growth; Walden achieved record total enrollment of ~52,400 students (Walden enrollment +13% year-over-year).
Strong Top-Line and Profit Growth
Consolidated revenue increased 12.4% to $503.4 million; consolidated adjusted EBITDA was $154.9 million, up 23.9%; adjusted operating income rose 24.3% to $126.1 million; adjusted net income increased 26.7% to $87.9 million; adjusted EPS of $2.43, up 34.3% year-over-year.
Exceptional Walden Performance
Walden revenue grew 27% to $217.6 million (or +16.5% excluding a one-week academic calendar shift), adjusted EBITDA rose 66.5% to $86.7 million, and adjusted EBITDA margin expanded to 39.8% (margin expansion ~940 bps year-over-year; ~400 bps excluding the timing shift).
MedVet Segment Improvement
Medical & Veterinary revenue increased 6.9% to $102 million; adjusted EBITDA rose 17.6% to $31.4 million and adjusted EBITDA margin improved 280 basis points to 30.8%; Ross Vet and AUC reported continued strong outcomes and pass-rate improvements.
Robust Cash Flow and Capital Allocation
Trailing twelve months operating cash flow was $428 million, up $146 million year-over-year; the company deployed $165 million to share repurchases in the quarter (repurchased 1.7M shares at an average price of $95), completed prior authorization and announced a new $750 million buyback authorization with ~$728 million available.
Upgraded EPS Guidance and Maintained Revenue Outlook
Raised adjusted EPS guidance to $7.80–$8.00 (growth ~17%–20%, midpoint +$0.15) while maintaining revenue guidance of $1.9–$1.94 billion (approximately 6%–8.5% growth); company expects ~100 bps full-year adjusted EBITDA margin expansion.
Operational and Academic Outcomes
Company highlighted continued investments in digital learning, program launches (Walden new programs enrolled >1,002 students in <1 year), improved USMLE step one pass rates via curriculum enhancements, and enrollment pathway innovations to expand access.